跳至主要内容
临床试验/CTRI/2021/08/035459
CTRI/2021/08/035459已完成不适用

Evaluation of skin safety of 4 test products for primary skin irritation using skin irritation test (Patch Test in Humans)IS 4011:2018 Guidelines.

Mosaic Wellness Private Limited1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2021年12月8日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
28
试验地点
1
主要终点
Evaluation of cutaneous tolerance by

研究概览

简要总结

The test products,

·       Minoxifin Solution  - B.No- WS2141

·       Endure Delay Gel  - B. No-O21DG001

·       Endure Long Last Spray  - B. No- EDL21001

·       Endure + Delay Spray  - B. No-2104042

were dermatologically tested and found to be “Non-Irritant†based on IS 4011 :2018,Methodsof Test for safety evaluation of cosmetics -Third Revision.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Voluntary men and women (preferably equal number of males and females) between 18 and 65 years.
  • Fitzpatrick skin type III to IV.
  • Having apparently healthy skin on test area.

排除标准

  • Pregnancy (by history) and lactating women.
  • Scars, excessive terminal hair, or tattoo on the studied area.
  • Hypersensitivity, allergy antecedent (to any cosmetic product, raw material, hair dye).

结局指标

主要结局

Evaluation of cutaneous tolerance by

时间窗: 48 hours scoring

dermatological scoring of skin reactions using

时间窗: 48 hours scoring

Draize scale

时间窗: 48 hours scoring

次要结局

未报告次要终点

研究者

申办方类型
Other [fmcg]

研究点 (1)

Loading locations...

相似试验

To evaluate the safety of 4 test products for skin... | 临床试验